研究疾病:
|
糖尿病周围神经病变
|
研究疾病代码:
|
|
Target disease:
|
Diabetic peripheral neuropathy
|
Target disease code:
|
研究类型:
Study type:
|
干预性研究
Interventional study
|
研究设计:
Study design:
|
随机平行对照
randomized controlled trial(parallel group design)
|
研究所处阶段:
Study phase:
|
其它
Others
|
研究目的:
|
本研究旨在通过调节因子HIF-1及其下游通路蛋白,探讨佤族临床常用药益气通络方缓解慢性组织缺氧,针对糖尿病周围神经病变“气虚血瘀”的基本病机,发挥益气活血、通络止痛作用的临床疗效和机制。
|
Objectives of Study:
|
The aim of this study is to explore the clinical therapeutic effect and mechanism of the drug commonly used in the treatment of chronic peripheral hypoxia in diabetic patients with peripheral neuropathy by regulating the factor HIF-1 and its downstream pathway proteins.
|
药物成份或治疗方案详述:
|
|
Description for medicine or protocol of treatment in detail:
|
|
纳入标准:
|
①西医诊断标准:中华医学会糖尿病学分会公布的《中国2型糖尿病防治指南(2021年版)》。a.明确的糖尿病病史;b.诊断糖尿病时或之后出现的神经病变;c.临床症状和体征与DPN的表现相符;d.有临床症状(疼痛、麻木、感觉异常等);e.5项检查(踝反射、针刺痛觉、震动觉、压力觉、温度觉)中任1项异常;无临床症状者,5项检查中任2项异常,临床诊断为DPN。
②中医证候诊断标准:参照2021年中国医师协会中西医结合医师分会内分泌与代谢病学专业委员会发布的《糖尿病周围神经病变病证结合诊疗指南》。DPN患者气虚血瘀型标准临床表现:a.符合消渴痹症临床症状和体征,手足麻木,如有蚁行,肢末时痛,多呈刺痛,下肢为主,入夜痛甚;b.气虚组症:神疲倦怠,气短懒言,动则汗出;c.气虚血瘀舌脉:舌质淡暗,或有瘀点,苔薄白,脉细涩。
③年龄范围在20-70岁,性别不限。
④知情同意,志愿受试,获得知情同意书过程符合GCP 规定。
|
Inclusion criteria
|
① Diagnostic criteria for western medicine: guideline for prevention and treatment of type 2 diabetes mellitus (2021 Edition) published by China Diabetes Association of Chinese Medical Association. A. has a clear history of diabetes mellitus; B. diagnosed diabetic neuropathy; or C., clinical symptoms and signs are consistent with DPN's performance; D. has clinical symptoms (pain, numbness, abnormal sensation, etc.); E.5 examination. (ankle reflex, acupuncture pain, vibration, pressure and temperature) is abnormal in any one item; if there are no clinical symptoms, any two of the five items are abnormal, and the clinical diagnosis is DPN.
② The diagnostic criteria of TCM syndromes: refer to the guidelines for the diagnosis and treatment of diabetic peripheral neuropathy combined with the 2021 issue of Endocrinology and metabolic diseases of Chinese Medical Doctor Association integrated traditional Chinese and Western medicine physicians' branch. The standard clinical manifestations of DPN patients with Qi deficiency and blood stasis type: A. meet the clinical symptoms and signs of Xiaoke Bi syndrome, numbness of hands and feet, pain at the end of limbs, mostly tingling, mainly lower limbs, and very painful at night; b. Qi deficiency syndrome: mental fatigue, shortness of breath, lazy speech, movement leads to sweating; c. Qi deficiency and blood stasis tongue pulse: the tongue is light and dark, or there are ecchymosis spots, the moss is thin and white, and the pulse is thin and astringent.
③ The age range is 20-70 years old, regardless of gender.
④ Informed consent, voluntary subjects, the process of obtaining informed consent was in accordance with the provisions of GCP.
|
排除标准:
|
①肝肾功能异常,血Cr、ALT、AST、BUN超出正常值2.5 倍以上者。
②合并高血压未得到有效控制者,严重的心、脑、肝及肾等脏器疾病,以及血液系统疾病或肿瘤。
③服用以下药物,如:丹参滴丸、葛根素、黄芪等中药制剂,含有激素等西药,以及含有上述成分的药品者。
④本次发病后正使用其他治疗DNP的益气活血类中成药。
⑤患者血糖等指标明显超过研究对象平均水平,或接受其他超常规的治疗,可能严重干扰研究对象基线水平者。
⑥妊娠期、哺乳期妇女。
⑦过敏性体质者等。
⑧精神或法律上的残疾患者。
⑨怀疑或确有酒精、药物滥用史,或者根据研究者的判断、具有降低入组可能性或使入组复杂化的其他病变,如工作环境经常变动等易造成失访的情况。
|
Exclusion criteria:
|
① Abnormal liver and kidney function, blood Cr, alt, AST and BUN exceeding the normal value by more than 2.5 times.
② Patients with hypertension not effectively controlled, serious heart, brain, liver, kidney and other organ diseases, as well as blood system diseases or tumors.
③ Take the following drugs, such as Danshen dropping pills, puerarin, Astragalus and other traditional Chinese medicine preparations, western drugs containing hormones and drugs containing the above ingredients.
④ After the onset of this disease, other Chinese patent medicines for supplementing qi and activating blood circulation for the treatment of DNP are being used.
⑤ Patients whose blood glucose and other indicators significantly exceed the average level of the study object, or receive other unconventional treatment, which may seriously interfere with the baseline level of the study object.
⑥ Pregnant and lactating women.
⑦ Allergic constitution, etc.
⑧ A mentally or legally disabled person.
⑨ Suspected or true history of alcohol and drug abuse, or other diseases that reduce the possibility of enrollment or complicate enrollment according to the judgment of the researcher, such as frequent changes in working environment, which are easy to cause loss of follow-up.
|
研究实施时间:
Study execute time:
|
从From
2022-01-01
至To
2022-06-30
|
征募观察对象时间:
Recruiting time:
|
从From
2022-01-01
至To
2022-06-01
|